On The Pen: The Weekly Dose 6.18.24
Вставка
- Опубліковано 18 чер 2024
- PBM Reform Form Letter:
Link to the Letter: www.onthepen.com/post/pbm-ref...
Express scripts (tiktok video on PBM reform):
Link to my video: • EXPRESS SCRIPTS: Chang...
Michigan (tiktok video)
Link (Madison Muller): www.bloomberg.com/news/articl...
Accessibility
Link: www.benefitspro.com/2024/06/1...
Vivani
Link: www.businesswire.com/news/hom...
Diet on GLP-1:
Link: www.upi.com/Health_News/2024/...
Link: onlinelibrary.wiley.com/doi/e...
Support the Show.
MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
/ @manonthemounjaro
Venmo: OnThePen
Ca$h App: ManOnMounjaro
BECOME A MEMBER HERE:
/ @manonthemounjaro
SOCIAL LINKS
/ manonthemounjaro
/ manonmounjaro
/ manonthemounjaro
/ manonthemounjaro
#Zepbound #releasethevials #mounjaro
📲 Contact Me: MounjaroMan@gmail.com
📼 PLAYLISTS:
🖊️ ON THE PEN LIVES:
• On The Pen: Live
👀 WATCH MY MOUNJARO JOURNEY IN ORDER:
• Mounjaro Weight Loss J...
😎 NERDS ONLY: LEARN ABOUT OTHER GLP-1 MEDS:
• New Weight Loss Meds
🚨📰 ALL THE LATEST MOUNJARO NEWS:
• GLP-1 News
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com.
I sent the letter to my state senator.
Awesome!!!!👏
Thank you so much for all your info!
We talk about the insurance not wanting to cover these drugs , maybe we should start focusing also on pharmaceutical companies charging so much for life altering medication. There has to be something that can be done to make it more affordable
Yes please! Stop defending Eli Lilly!
No one is defending Eli Lilly (or Novo) on pricing.
Most everyone here knows the prices are too high… and is happy to say so. 🤷♂️
To be clear, insurance is not paying full-price for any of these medications.
Lee is my friend!!! Yeah!! We live in the same small town 😂
🧡🧡
Is that a hat for Walter?
Busted!
Thank you for the form letter! I contacted my representatives. Thanks for making it easy!
Awesome thanks for doing it!
Dave, does that mean for those of us that have been on GLP1s for the past six months will now have to go back to a six-month step therapy and behavioral mod education? Or will they grandfather in those already being helped by GLP1s. Thanks so much for your daily information.
I don’t think there will be any “grandfathering”
Any more about Robelis 50 mg for the month of July
You just can never spell that, can ya? 😏
Done ✔️❤
Thanks!
Thank you!!
Great information as always thank you❤Peggy
I’m sorry. I love Dave. At 7:36 he says “kudos to Eli Lilly” which is the wrong message. Why give them kudos when the shortage continues. Do we need to release the vials? It seems like the API is the problem for Eli. Otherwise why are they spending so much on API domestic production? Is it the pen that is the “some of the most complex things on the planet to manufacture?” Really? Apple oversees the manufacture of iPhones with over 1000 raw material parts with a core processor that has transistor traces at 1/20,000th of a human hair. And a pen is complicated? Fire the CEO that says something like that. Stop defending the rich CEO. You love this community. Let’s hold Eli to account.
I don’t disagree with your points you’re making here. I’ll have to go back and watch and see what I was “kudosing” them on. It definitely isn’t how they’re handling the shortage.
But let’s not also forget, they’re bringing us the very medicine we’re all clamoring to get our hands on….
@@ManOnTheMounjaro I do love you, your heart, your faith and the work you do on behalf of this community. I am grateful for the medicine, and have been on it since January. I haven’t missed a shot and consider myself blessed. It’s not just Eli that brings us the medicine. Compounding pharmacies also deliver it to many of us. Thanks be for compounding. If we are going to rally as a community let’s not set our sights low. Let’s understand what we can do to support Sanders’ efforts to push the process down. I know you covered that news. I heard it from you. Why not?
Compounders can indeed be very helpful during times when Lilly (and Novo) are unable to keep up with demand, yes. 🙏
But, compounders did not research or develop these meds. A long and expensive process. 🧪
Nor did they pay for or run the extensive clinical trials for same that proved safety, efficacy, and proper dosing.
(Good) compounders are a benefit, but without Lilly and Novo, what they’re compounding regarding GLP-1 meds is bup and kiss… and kiss just left town. 🤷♂️
Thankful for them and the role they play. But, they don’t invent anything.
@@cloakster I don’t understand this perspective. Do you think people don’t know that Eli did the R&D to bring tirz to market or do you think that because they did they should be able to charge any price or behave any way that they want? I don’t have loyalty to Eli. They are a for profit business. I don’t have loyalty to compounders. They are also for profit businesses.
I have loyalty to this community. We don’t owe Eli or Novo anything. If they didn’t do the R&D someone else would have. If you want to pay whatever price Eli wants to charge, and you don’t care that they choose to spend a lot of money on fear monger campaigns instead of investing more to reduce price, increase supply, and increase access to tirz, it’s a free market. I just think this community should advocate for access and not advocate for large pharma companies. They literally have billions of dollars that have come from people who use their product (like us) and they already spend enough of it advocating for themselves.
@Chi I don’t understand why you don’t understand.
You’re either a newcomer here or a longtime lurker/semi-lurker (and if it’s the latter, good on you for speaking up more)… but if you’re a lurker, then you would’ve seen me criticize Lilly and Novo on access (prices too high, supply too low) MANY times. Dave does so too, though perhaps somewhat less bluntly.
And if you’re a newcomer, then you would simply be making baseless assumptions as to what Dave or I think. 🤔
Another inaccurate, or at least non-nuanced, assumption would be that ‘if Lilly or Novo didn’t create these meds, someone else would have’.
Perhaps… but WHEN? ⏱
I think ppl forget the big Phen-fen disaster of the late ‘90s, and how it and other big disappointments in the obesity medications space led to almost all the major companies concluding that there was really ‘no there, there’ regarding these kinds of meds.
Really, for Lilly and Novo to pursue GLP-1 meds for as long and hard as they did was very definitely going against the grain of almost the entire industry.
And if they *hadn’t,* it likely would’ve been a very long time before someone else would’ve come along and finally did it. Other companies didn’t see the potential/were part of a conventional wisdom that said that obesity meds were a quagmire. 😯
You and I would certainly not be having this conversation about them, at least probably not ‘til the 2030s or 2040s. And maybe not at all, if obesity co-morbidities had caused the untimely passing of one or both of us prior. 😕
I do get the view that Lilly and Novo are for-profit companies, and, for all their vision, are pretty aggressive about it.
I don’t ‘love’ either company. The meds are priced too high, and they did a fairly poor job of forecasting (and preparing for) demand, and are belatedly ramping up/playing catch-up.
I know this, Dave knows this, and most of the GLP-1 community knows this. Yet you seem to think you’re bringing us some hard-hitting new perspective. Trust me, you are not.
And to explore that further, Dave, I, and others have advocated for the following:
- Passage of the Treat and Reduce Obesity Act.
- PBM Reform (in fact, Dave just did a vid on this). Not a Lilly/Novo thing, but goes to pricing in a major way.
- The US govt negotiating the price of GLP-1 medications for Medicare, under the provisions of The Inflation Reduction Act.
So… pls tell me again how we’re somehow indiscriminate Lilly/Novo fanboys, or are okay with the current pricing and access situation? 🤷♂️
Far as Sanders’ recent efforts to put a little heat on Novo over pricing goes… all for it.
Though last I checked, he wasn’t going after Lilly - a US company - with the same zeal… apparently only Danish Novo is going to be grilled before the Senate.
Perhaps this is political, aka not wanting to give Repubs an opportunity to attack Dems as somehow being ‘anti-American business’ right before an election.
Whatever the reasoning, do hope Lilly gets called in for a grilling post-election. 🤔
Anyhow Chi, maybe the broader point’s been made… my stance on these companies, as well as Dave’s, is a lot more nuanced and way less ‘always pro’ than you seem to realize.
And I think one can criticize a company LOTS on matter of access - as I do, as Dave and others here do - while at the same time acknowledging that the invention and development of modern GLP-1s is an amazing and positive thing. 👍
Especially since no one else seemed to have the vision/was willing to commit the resources… at least not in any kind of timeframe that would be helping us today. ✅
IOW, it’s not black-and-white. It’s a mixed bag and complicated, as things like this tend to be.